New medication limits the number of injections to treat macular edema — 5 things to know

Researchers found a new procedure to prevent a common diabetic eye disease.

Advertisement

Here are five things to know:

1. Many people who have diabetes also get diabetic macular edema, said Caesar Luo, MD, a retinal specialist.

2. Typical treatment for macular edema is a monthly eye injection to help bring back some vision, but it comes with significant costs and straining, as well as frequent physician visits.

3. The new medication, called Iluvien, is an FDA-approved implant that slowly releases the medication for 36 months.

4. The procedure involves numbing the eye completely and injecting once into the eye.

5. Despite this advancement, it’s suggested that people with diabetes continue to manage their conditions properly.

More articles on healthcare:
Too much screen time may cause nearsightedness in children — 5 things to know
High long-term survival rates for postop PCa patients — 5 key points
This outpatient surgery center is also an ‘idea center’ — 5 things to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC News

Advertisement

Comments are closed.